European Investment Bank

Norlase is a global ophthalmic medical device company specializing in next-generation laser solutions for retina and glaucoma treatments. They offer innovative products like ECHO, the world's first portable pattern laser with wireless capabilities and voice control, and LEAF, an ultra-compact green laser photocoagulator that attaches directly to slit lamps.

Median Technologies develops medical imaging software and services for oncology clinical trials and cancer care. It offers iBiopsy, an AI-powered imaging biomarker phenotyping platform that supports translational research and biomarker identification, and iSee, an image analysis and management solution for clinical trials. The company standardizes and automates the interpretation of medical images to optimize cancer diagnosis and the assessment of treatment response, and provides imaging contract research services such as study startup, image and clinical data management, scientific consulting, independent reviews, image data processing, site support, and study close-out. Median Technologies serves drug development and patient care markets with international reach and has partnerships with industry players to expand imaging capabilities. It was founded in 2002 and is headquartered in Valbonne, France.

Cellectis is a clinical-stage biotechnology company specializing in immuno-oncology. It develops allogeneic T-cell therapies using gene-editing technologies, focusing on chimeric antigen receptor (CAR) T-cells targeting various cancers.

TactoTek develops and licenses Injection-Molded Structural Electronics (IMSE®) technologies. It enables global manufacturers to integrate circuits into plastic parts, creating smart interactive surfaces for automotive, aviation, connected home, industrial control, and medical industries.

LUMICKS develops innovative technologies for studying biology and cancer at single-molecule and single-cell levels. Its products include C-Trap Optical Tweezers, Fluorescence Microscopy, and z-Movi Cell Avidity Analyzer, enabling real-time analysis of complex biological processes and interactions.

WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

Protembis GmbH, established in 2017 and based in Aachen, Germany, specializes in the development of innovative surgical equipment, particularly focusing on minimally invasive medical devices. The company's flagship product, the ProtEmbo System, is an intra-aortic filter designed to mitigate the risk of cerebrovascular events during transcatheter aortic valve replacement (TAVR) procedures. This device effectively deflects embolic material generated during these cardiovascular interventions away from the cerebral circulation, thereby reducing the likelihood of brain injury. By enhancing the safety of TAVR, Protembis aims to improve patient outcomes, particularly as this procedure becomes more common among younger and lower-risk individuals. Through its advancements, Protembis is committed to increasing the quality of life for patients while also addressing the broader healthcare costs associated with complications arising from surgical interventions.

Nyxoah focuses on developing and commercializing solutions to treat sleep-disordered breathing conditions. Its primary product is the Genio system, a CE-Mark validated bilateral neuro-stimulation therapy for moderate to severe obstructive sleep apnea.

Wandercraft is a robotics company that develops self-balancing robotic exoskeletons to enable paralyzed users to stand and walk hands-free, without crutches. Its flagship exoskeleton, Atalante, is a commercial device designed for daily life and rehabilitation, CE-marked in 2019 and marketed to European rehab hospitals to support gait re-learning. The company combines algorithmics, AI, robotics, production, clinical, marketing and sales to deliver a full-stack solution and aims to bring a realistic, autonomous walking device beyond lab prototypes. The exoskeleton uses motors at each joint controlled by a computing unit running software that computes robotic algorithms every millisecond to replicate a human gait, enabling paraplegic individuals to regain autonomy during daily activities.

Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

Amplifon is a leading international provider of hearing care solutions and services, dedicated to helping individuals rediscover the joys of sound. The company offers a wide range of customizable hearing products that are tailored to meet the unique needs of consumers. Amplifon operates through a comprehensive distribution network that includes corporate shops, franchises, and shop-in-shops, allowing it to reach various markets effectively. It has a significant presence in the EMEA region, which accounts for most of its revenue, while also having a footprint in the Americas and Asia-Pacific. Amplifon markets its offerings under several brands, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear, with a notable concentration of retail locations in Italy. Through its commitment to innovative technology and personalized service, Amplifon strives to deliver the highest quality hearing care experience to its customers.

Founded in Munich, Germany in 2014, Smart Reporting offers a digital health solution for structured medical reporting. Its platform improves report quality and efficiency by providing radiologists with automated report generation, guideline-compliant criteria application, and integration into existing systems.

Neuromod Devices, established in 2010 and headquartered in Dublin, Ireland, is a medical device company dedicated to the research and development of neuromodulation treatments for chronic tinnitus. The company's core product, the Mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the human nervous system. Neuromod's mission is to empower patients worldwide, including the 10% of adults affected by chronic tinnitus, by delivering targeted, non-invasive therapies that seamlessly integrate into daily life.

Cellectis is a clinical-stage biotechnology company specializing in immuno-oncology. It develops allogeneic T-cell therapies using gene-editing technologies, focusing on chimeric antigen receptor (CAR) T-cells targeting various cancers.

SpinDiag GmbH is a German company specializing in the development of automated point-of-care systems for the rapid detection of infectious diseases. Founded in 2016 and headquartered in Freiburg, SpinDiag manufactures a compact, user-friendly centrifugal-microfluidic test system that enables healthcare professionals to detect drug-resistant bacteria and other pathogens directly from patient samples. Its flagship product, which includes an automated SARS-CoV-2 test, allows for the screening of up to 25 antibiotic resistances upon patient admission, effectively preventing the spread of infections by isolating affected individuals. The system streamlines the testing process with a fully automated workflow that can be operated by nursing staff, providing laboratory-grade PCR results from standard swab samples without the need for additional sample collection. By integrating this technology into everyday clinical practice, SpinDiag enhances diagnostic efficiency and safety in healthcare settings.

Ovagen is a biotechnology company specializing in the commercial production of germ-free chicken eggs and birds. Primarily serving the pharmaceutical industry, Ovagen offers contract research services and expertise in specific poultry and rodent research technologies to Good Manufacturing Practice (GMP) standards.

Founded in 2017, Loci Orthopaedics specializes in developing innovative medical technologies for orthopedics. The company is renowned for its InDx implant, the only device that fully mimics natural thumb joint motions and offers a less invasive surgical treatment option.

POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, that specializes in innovative in-vitro diagnostic solutions. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which enables real-time, reagentless analysis of human fluids and specimens. This fully automated system allows for the rapid detection, quantification, and identification of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just minutes. By streamlining the diagnostic process, POCARED Diagnostics enhances the ability of physicians to quickly diagnose and treat infectious diseases, ultimately improving patient outcomes. The company operates as a subsidiary of Naftali Investments Ltd.

TRUMPF is a high-technology company that manufactures sheet metal fabrication machinery, power tools, industrial lasers, and medical technologies. It provides production solutions across machine tool, laser and electronics sectors and drives digital connectivity in manufacturing through consulting, platforms and software offerings. As an independent, family-owned business, TRUMPF operates with a long-term perspective and sustains its innovative strength. The company serves global markets and is recognized as a leader in machine tools and laser technology, delivering systems such as laser cutting, welding, marking and additive production equipment that optimize upstream and downstream manufacturing processes.

Founded in Munich, Germany in 2013, DyeMansion specializes in transforming raw, 3D-printed polymer parts into high-value consumer and industrial products. The company offers precision coloring and finishing systems that work with major industrial powder-bed 3D printing systems, enabling high-volume production for diverse applications.

USound designs, develops, and manufactures advanced audio systems based on Micro ElectroMechanical Systems (MEMS) technology for mobile applications worldwide. Its products include integrated audio smart systems used in smartphones, headphones, hearing aids, and other devices.

eCential Robotics specializes in minimally invasive surgical solutions aimed at enhancing routine clinical practices. The company develops advanced imaging technology that integrates fluoroscopy, surgical navigation, and robotics, specifically tailored for orthopedic and trauma surgeries. Its innovative system offers high-definition imaging and real-time navigation, allowing surgeons to conduct various procedures with increased safety and precision. By facilitating day surgery, eCential Robotics provides significant benefits to patients, hospitals, clinics, and overall healthcare systems, while also minimizing radiation exposure during complex interventions.

Essity is a health and hygiene company that develops, manufactures, and sells personal care products and medical solutions. Spun out from Svenska Cellulosa in 2017, it is headquartered in Stockholm, Sweden. The company offers a broad range of consumer products, including feminine care, baby care, toilet paper, facial tissue, wet wipes, hand soap, hand sanitizers, and tissue dispensers for institutional customers, as well as medical solutions in wound care, orthopedics, and compression therapy. Essity operates in about 150 markets and around 60% of net sales come from Europe.

miDiagnostics is a Belgian company focused on creating innovative testing solutions that allow individuals to perform blood analyses independently. The company is developing a novel chip-based technology that enables the rapid detection of various biomarkers from minimal blood samples, such as those obtained from a finger prick. This technology integrates a nanofluidic processor with a compact reader, facilitating the measurement of cells, proteins, nucleic acids, and small molecules. By providing disposable tests that are easy to use and offer built-in connectivity, miDiagnostics aims to enhance diagnostic capabilities for both patients and clinicians, making lab-quality testing accessible anytime and anywhere.

Xeltis is a clinical-stage medical device company developing bio-absorbable heart valves and blood vessels. Its RestoreX technology enables the body's natural healing system to create functional tissue within its devices, forming new valves or vessels over time. Headquartered in Zurich, Switzerland, with R&D and manufacturing facilities in Eindhoven, Netherlands, Xeltis aims to transform cardiovascular care.

Quantum Surgical develops surgical robotics and intelligent tools to democratize minimally invasive liver cancer treatment. The company's robotics support percutaneous ablation therapies and related minimally invasive procedures, aiming to improve patient outcomes and safety in interventional oncology. By enabling precise robotic assistance, Quantum Surgical seeks to help healthcare providers perform safer, more effective liver cancer interventions, with potential for higher cure rates and shorter recovery times.

Brolis Sensor Technology is a specialized company focused on developing and manufacturing advanced spectroscopic sensors tailored for medical and fitness applications. Established in 2019 as a distinct entity within Brolis Group, the company offers ultra-compact, laser-based integrated sensor systems capable of multi-molecule sensing throughout the bloodstream. This innovative technology empowers individuals to monitor their health more effectively, promoting personalized healthcare solutions that enhance overall well-being.

Scope Fluidics S.A. is a Polish company specializing in the development and manufacturing of diagnostic devices, particularly focusing on innovative microfluidic systems for the collection of micro-samples of blood and the storage of reagents for diagnostic markers. Founded in 2010 at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw, the company aims to address global health challenges through advanced diagnostic and medical technology solutions. Scope Fluidics collaborates closely with academia and integrates insights from various fields, including medicine and business, to create high-potential innovations. The company operates through special purpose vehicles, including Curiosity Diagnostics and Bacteromic, each dedicated to specific projects. By fostering a collaborative environment among physicians, engineers, and scientists, Scope Fluidics develops effective solutions tailored to meet social needs and market demands.

Median Technologies develops medical imaging software and services for oncology clinical trials and cancer care. It offers iBiopsy, an AI-powered imaging biomarker phenotyping platform that supports translational research and biomarker identification, and iSee, an image analysis and management solution for clinical trials. The company standardizes and automates the interpretation of medical images to optimize cancer diagnosis and the assessment of treatment response, and provides imaging contract research services such as study startup, image and clinical data management, scientific consulting, independent reviews, image data processing, site support, and study close-out. Median Technologies serves drug development and patient care markets with international reach and has partnerships with industry players to expand imaging capabilities. It was founded in 2002 and is headquartered in Valbonne, France.

Ottobock is a designer and manufacturer of prosthetic limbs dedicated to enhancing the mobility and quality of life for individuals with disabilities. The company focuses on innovative solutions, offering products such as a computerized knee that adapts its resistance to accommodate various walking gaits, and a fully articulated robotic hand prosthesis. These advancements enable users to overcome challenges associated with their disabilities, promoting independence and active lifestyles. Driven by a commitment to innovation and the desire to provide optimal support for those in need, Ottobock strives to improve the overall well-being of its customers.

Vivasure Medical Limited is a medical device company based in Galway, Ireland, that specializes in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures, primarily in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, designed to effectively close large arteriotomies resulting from transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Founded in 2008, Vivasure Medical is committed to advancing techniques that enhance patient outcomes in vascular access procedures.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Aerogen Limited is a medical device and drug delivery company based in Galway, Ireland, specializing in aerosol drug delivery systems for the critical care respiratory market. Founded in 1997, Aerogen has developed a range of products, including the Aerogen Solo and Aerogen Ultra nebulizers, designed for various patient needs, including those on life-support ventilation and spontaneous breathing. The company utilizes its patented Vibronic aerosol technology, which nebulizes drugs into a fine particle mist for effective lung absorption while preserving drug integrity. Aerogen's products are utilized in over 65 countries and are crucial in both acute care and home care settings. With a strong emphasis on research and development, the company employs a highly educated workforce, with more than 95% of its employees holding degrees in science and engineering. Aerogen also collaborates with prominent Irish research institutes to enhance its product offerings and support its continued growth in the global market.

Nanobiotix SA is a clinical-stage biotechnology company based in Paris, France, focused on advancing cancer treatment through its innovative nanomedicine programs. The company is known for its proprietary NanoXray technology, which enhances the effectiveness of radiotherapy by amplifying its impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its key products, NBTXR3, is a radio-enhancer composed of hafnium oxide designed for treating various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. Founded in 2003, Nanobiotix is dedicated to transforming cancer therapy and improving patient outcomes using its advanced nanotechnology solutions.

Carmat is a French medtech company that specializes in the development and manufacturing of bioprosthetic artificial hearts. Founded in 2008 and headquartered in Vélizy-Villacoublay, the company creates biocompatible, auto-regulated total artificial hearts designed to closely mimic the human heart's structure, including both right and left ventricles. These devices are intended for patients suffering from chronic terminal heart failure classified as class IV by the New York Heart Association, as well as those experiencing acute terminal heart failure due to massive myocardial infarction. Carmat aims to provide a reliable and innovative therapeutic solution for heart failure patients who are ineligible for transplants and have exhausted other treatment options. In addition to the artificial hearts, the company develops the necessary power supply systems and remote diagnostic systems for these devices.

Nanobiotix SA is a clinical-stage biotechnology company based in Paris, France, focused on advancing cancer treatment through its innovative nanomedicine programs. The company is known for its proprietary NanoXray technology, which enhances the effectiveness of radiotherapy by amplifying its impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its key products, NBTXR3, is a radio-enhancer composed of hafnium oxide designed for treating various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. Founded in 2003, Nanobiotix is dedicated to transforming cancer therapy and improving patient outcomes using its advanced nanotechnology solutions.

Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.

medneo is a German diagnostic imaging company that provides radiology as a service, operating diagnostic centers and a teleradiology network. It offers pay-per-use solutions for diagnostic image acquisition and reporting to clinicians, medical centers and hospitals. The company deploys diagnostic imaging platforms to deliver medical images to customers rather than selling equipment, aiming to improve process efficiency, maximize equipment utilization, enhance image quality and service, and reduce costs, thereby improving patient access and reducing waiting times. Based in Berlin, medneo serves physicians, hospitals and research institutes with its imaging platforms and teleradiology services.

Cellnovo is a medical device company focused on diabetes management. The company develops and markets an integrated system that connects various components of diabetes care through mobile technology. Its product portfolio includes a cordless micro-pump, an integrated monitoring device, and a cellular handset equipped with a touch screen and an embedded blood glucose meter. This innovative system allows for automatic data transmission, enabling patients and healthcare providers to effectively monitor the patient's condition in real-time.

NewIcon Oy is a health technology company established in 2007, recognized as the market leader in pharmacy automation systems in Finland. The company specializes in developing automated medication dispensing systems tailored for both hospitals and retail pharmacies. By leveraging robotics and advanced software, NewIcon enhances efficiency and safety in medication distribution, allowing healthcare providers to prioritize patient care. With a workforce of approximately 70 employees, NewIcon has successfully delivered pharmacy automation solutions to over 100 pharmacies and hospitals across several countries, including Denmark, Russia, Israel, Iran, and China. The company maintains a commitment to quality, operating under a certified ISO 9001 quality management system, and has achieved a turnover exceeding €7 million.

Bavarian Nordic is a biotechnology company focused on developing and producing vaccines for life-threatening diseases with significant unmet medical needs. Its primary areas of focus are biodefense, cancer, and infectious diseases.

TreeFrog Therapeutics is a stem cell company focused on scalable production of stem cells for cell therapies. It develops and uses a proprietary end-to-end 3D bioreactor-based platform called C-Stem to enable scalable, cGMP-compliant manufacturing. Founded in 2018 and based in Pessac, France, the company aims to secure cell production and quality, accelerate clinical development, and improve market access by reducing treatment costs. The platform addresses manufacturing bottlenecks in the cell therapy sector, offering an integrated solution from cell culture to manufacturing readiness to support safe, affordable stem cell therapies.